The association between HbA1c/C-peptide levels and short-term mortality in patients diagnosed with myocardial infarction

References

• Group Sw, collaboration ESCCr. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021;42(25):2439–2454.
   PubMed Web of Science ®Google Scholar
• Marx N, Federici M, Schutt K, et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023;44(39):4043–4140.
   PubMed Web of Science ®Google Scholar
• Silva S, Fatumo S, Nitsch D. Mendelian randomization studies on coronary artery disease: a systematic review and meta-analysis. Syst Rev. 2024;13(1):29. doi:10.1186/s13643-023-02442-8
   PubMed Web of Science ®Google Scholar
• Sarebanhassanabadi M, Mirjalili SR, Marques-Vidal P, et al. Coronary artery disease incidence, risk factors, awareness, and medication utilization in a 10-year cohort study. BMC Cardiovasc Disord. 2024;24(1):101. doi:10.1186/s12872-024-03769-3
   PubMed Web of Science ®Google Scholar
• American Diabetes A. 6. Glycemic targets: standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl. 1):S73–S84. doi:10.2337/dc21-S006
   PubMedGoogle Scholar
• Cavero-Redondo I, Peleteiro B, Alvarez-Bueno C, et al. Glycated haemoglobin A1c as a risk factor of cardiovascular outcomes and all-cause mortality in diabetic and non-diabetic populations: a systematic review and meta-analysis. BMJ Open. 2017;7(7):e015949. doi:10.1136/bmjopen-2017-015949
   PubMed Web of Science ®Google Scholar
• Wahren J, Larsson C. C-peptide: new findings and therapeutic possibilities. Diabetes Res Clin Pract. 2015;107(3):309–319. doi:10.1016/j.diabres.2015.01.016
   PubMed Web of Science ®Google Scholar
• Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010;362(9):800–811. doi:10.1056/NEJMoa0908359
   PubMed Web of Science ®Google Scholar
• Hadjadj S, Coisne D, Mauco G, et al. Prognostic value of admission plasma glucose and HbA in acute myocardial infarction. Diabet Med. 2004;21(4):305–310. doi:10.1111/j.1464-5491.2004.01112.x
   PubMed Web of Science ®Google Scholar
• Toprak K, Kaplangoray M, Memioglu T, et al. HbA1c/C-peptide ratio is associated with angiographic thrombus burden and short-term mortality in patients presenting with ST-elevation myocardial infarction. Blood Coagul Fibrinolysis. 2023;34(6):385–395. doi:10.1097/MBC.0000000000001240
   PubMed Web of Science ®Google Scholar
• Toprak K, Kaplangoray M, Memioglu T, et al. The HbA1c/C-peptide ratio is associated with the no-reflow phenomenon in patients with ST-elevation myocardial infarction. Angiology. 2023;75:33197231213166. doi:10.1177/00033197231213166
   Google Scholar
• Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J Acute Cardiovasc Care. 2024;13(1):55–161.
   PubMed Web of Science ®Google Scholar
• Libby P, Pasterkamp G, Crea F, et al. Reassessing the mechanisms of acute coronary syndromes. Circ Res. 2019;124(1):150–160. doi:10.1161/CIRCRESAHA.118.311098
   PubMed Web of Science ®Google Scholar
• Asada Y, Yamashita A, Sato Y, et al. Thrombus formation and propagation in the onset of cardiovascular events. J Atheroscler Thromb. 2018;25(8):653–664. doi:10.5551/jat.RV17022
   PubMed Web of Science ®Google Scholar
• Marti D, Salido L, Mestre JL, et al. Impact of thrombus burden on procedural and mid-term outcomes after primary percutaneous coronary intervention. Coron Artery Dis. 2016;27(3):169–175. doi:10.1097/MCA.0000000000000317
   PubMed Web of Science ®Google Scholar
• Srikanth S, Ambrose JA. Pathophysiology of coronary thrombus formation and adverse consequences of thrombus during PCI. Curr Cardiol Rev. 2012;8(3):168–176. doi:10.2174/157340312803217247
   PubMedGoogle Scholar
• Libby P. Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med. 2013;368(21):2004–2013. doi:10.1056/NEJMra1216063
   PubMed Web of Science ®Google Scholar
• Angiolillo DJ, Roffi M, Fernandez-Ortiz A. Tackling the thrombotic burden in patients with acute coronary syndrome and diabetes mellitus. Expert Rev Cardiovasc Ther. 2011;9(6):697–710. doi:10.1586/erc.11.76
   PubMedGoogle Scholar
• Grunberger G, Sima AA. The C-peptide signaling. Exp Diabesity Res. 2004;5(1):25–36. doi:10.1080/15438600490424497
   PubMedGoogle Scholar
• Queen LR, Ji Y, Goubareva I, et al. Nitric oxide generation mediated by beta-adrenoceptors is impaired in platelets from patients with Type 2 diabetes mellitus. Diabetologia. 2003;46(11):1474–1482. doi:10.1007/s00125-003-1219-0
   PubMed Web of Science ®Google Scholar
• Zheng J, Cheng J, Zhang Q, et al. Association between glycosylated hemoglobin level and cardiovascular outcomes in diabetic patients after percutaneous coronary intervention. Medicine (Baltimore). 2016;95(19):e3696. doi:10.1097/MD.0000000000003696
   PubMed Web of Science ®Google Scholar
• Vivas D, Garcia-Rubira JC, Bernardo E, et al. Influence of HbA1c levels on platelet function profiles associated with tight glycemic control in patients presenting with hyperglycemia and an acute coronary syndrome. A subanalysis of the CHIPS Study (“Control de HIperglucemia y Actividad Plaquetaria en Pacientes con Sindrome Coronario Agudo”). J Thromb Thrombolysis. 2013;35(2):165–174. doi:10.1007/s11239-012-0834-3
   PubMed Web of Science ®Google Scholar
• Lindenblatt N, Braun B, Menger MD, et al. C-peptide exerts antithrombotic effects that are repressed by insulin in normal and diabetic mice. Diabetologia. 2006;49(4):792–800. doi:10.1007/s00125-006-0152-4
   PubMed Web of Science ®Google Scholar
• Forst T, Kunt T. Effects of C-peptide on microvascular blood flow and blood hemorheology. Exp Diabesity Res. 2004;5(1):51–64. doi:10.1080/15438600490424532
   PubMedGoogle Scholar
• Forst T, De La Tour DD, Kunt T, et al. Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I. Clin Sci (Lond). 2000;98(3):283–290. doi:10.1042/cs0980283
   PubMed Web of Science ®Google Scholar
• Young LH, Ikeda Y, Scalia R, et al. C-peptide exerts cardioprotective effects in myocardial ischemia-reperfusion. Am J Physiol Heart Circ Physiol. 2000;279(4):H1453–1459. doi:10.1152/ajpheart.2000.279.4.H1453
   PubMed Web of Science ®Google Scholar
• Alves MT, Ortiz MMO, Dos Reis G, et al. The dual effect of C-peptide on cellular activation and atherosclerosis: protective or not? Diabetes Metab Res Rev. 2019;35(1):e3071. doi:10.1002/dmrr.3071
   PubMed Web of Science ®Google Scholar